Active ingredient
Results: 540
# | Item |
---|---|
501![]() | Clinical Pharmacology BPCA Summary Submission: Stamp Date: Trade Name: Acting Team Leader: Active Ingredient:Add to Reading ListSource URL: www.fda.govLanguage: English |
502![]() | NDA #20297 Supplement amendment: 022 dated September 1, 2006 Sponsor: GlaxoSmithKline Name of Finished Product: Coreg® Name of Active Ingredient: carvedilol Proposed indication: pediatric patients with symptomatic systeAdd to Reading ListSource URL: www.fda.govLanguage: English |
503![]() | ICH Consensus Guideline Released for Consultaton on 10 May 2005, at Step 2 of the ICH ProcessAdd to Reading ListSource URL: www.fda.govLanguage: English |
504![]() | These medicines all have one thing in common[removed]the same active ingredient. Taking too much of the same activeAdd to Reading ListSource URL: www.fda.gov |
505![]() |